Emergent BioSolutions Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Emergent BioSolutions Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Emergent BioSolutions Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $12.4M, a 27.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.4M -$4.7M -27.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $13.7M -$2M -12.7% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.3M -$200K -1.29% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $16.2M -$3.2M -16.5% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $17.1M -$3.4M -16.6% Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $15.7M -$9.8M -38.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $15.5M -$11.4M -42.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $19.4M -$8.9M -31.4% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $20.5M -$7.9M -27.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $25.5M -$4.1M -13.9% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $26.9M -$2.8M -9.43% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $28.3M -$2.7M -8.71% Dec 31, 2021 10-K/A 2023-12-11
Q3 2021 $28.4M +$5M +21.4% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $29.6M +$5.1M +20.8% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $29.7M +$4.1M +16% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $31M +$6.3M +25.5% Dec 31, 2020 10-Q 2021-11-05
Q3 2020 $23.4M +$4M +20.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $24.5M +$8.8M +56.1% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $25.6M +$12.7M +98.5% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $24.7M Dec 31, 2019 10-Q 2020-11-06
Q3 2019 $19.4M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $15.7M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $12.9M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.